Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Toxicology ; 169(2): 153-61, 2001 Dec 14.
Artigo em Inglês | MEDLINE | ID: mdl-11718956

RESUMO

Carbofuran (CF) is one of the most widely used carbamate pesticides in the world applied for insect and nematode control. Due to its widespread use in agriculture and households, contamination of food, water, and air has become serious, and consequently adverse health effects are inevitable in humans, animals, wildlife and fish. It has been reported that CF alone or in combination with other carbamate insecticides influences the level of reproductive and metabolic hormones such as thyroxine and corticosterone, and results in impairment of endocrine, immune and behavioral functions. In this study, we evaluated the effects of CF and its metabolite, the N-nitroso derivative N-nitrosocarbofuran (NOCF), on genotoxicity, cell growth, cell cycle and apoptosis of Chinese hamster lung fibroblast (CHL) cells. NOCF, but not CF, induced genotoxicity determined by Ames test. NOCF inhibited the growth of Chinese hamster lung fibroblast (CHL) cells with an IC(50) of 12.8 microM. NOCF induced apoptosis of CHL cells, which was demonstrated by morphological changes, DNA fragmentation and flow cytometric analysis. Treatment of CHL cells with NOCF induced significant G(2)/M cell cycle arrest. Caspase-3, an executioner of apoptosis was also activated by the treatment of CHL cells with NOCF. These results suggest that NOCF, that is an important metabolite of CF, leads to the induction of cell cycle arrest and apoptosis in CHL cells.


Assuntos
Apoptose/efeitos dos fármacos , Carbofurano/toxicidade , Inseticidas/toxicidade , Resíduos de Praguicidas/toxicidade , Animais , Carbofurano/análogos & derivados , Caspase 3 , Caspases/metabolismo , Ciclo Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Cricetinae , Cricetulus , Fragmentação do DNA , Fibroblastos/efeitos dos fármacos , Citometria de Fluxo , Marcação In Situ das Extremidades Cortadas , Pulmão/citologia , Pulmão/efeitos dos fármacos , Testes de Mutagenicidade
2.
Biol Pharm Bull ; 24(5): 480-3, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11379764

RESUMO

2-1(4-Cyanophenyl)aminol-3-chloro-1,4-naphthalenedione (NQ-Y15) is a dual action drug which acts as a thromboxane A2 (TXA2) synthase inhibitor and TXA2/PGH2 receptor antagonist. In the present study, we examined the effects of NQ-Y15 on Ca2+ mobilization, which is the common event in various types of platelet activation, in arachidonic acid (AA)-stimulated rat platelets. The elevation of cytosolic Ca2+ concentration ([Ca2+]i) induced by AA was inhibited by NQ-Y15 in a concentration-dependent manner. This inhibition-effect of NQ-Y15 was found to be based on the suppression of the rise in [Ca2+]i by the inhibition of both Ca2+ release from internal stores and Ca2+ influx from the extracellular space. Our successive trial was focused on the role of cyclic AMP (cAMP) in the action of NQ-Y15, because cAMP was reported to be increased by dual action drugs such as picotamide and to inhibit the increase in [Ca2+]i. NQ-Y15 was confirmed to increase cAMP in AA-stimulated rat platelets. These results suggested that NQ-Y15 might inhibit the rise in [Ca2+]i in AA-treated rat platelets by increasing cAMP, which is involved in the inhibition of platelet activation.


Assuntos
Plaquetas/efeitos dos fármacos , Cálcio/metabolismo , AMP Cíclico/biossíntese , Inibidores Enzimáticos/farmacologia , Naftoquinonas/farmacologia , Inibidores da Agregação Plaquetária/farmacologia , Tromboxano-A Sintase/antagonistas & inibidores , Animais , Ácido Araquidônico/farmacologia , Plaquetas/metabolismo , Feminino , Prostaglandina D2/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de Tromboxanos/antagonistas & inibidores
3.
Toxicol Lett ; 119(2): 143-55, 2001 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-11311576

RESUMO

The effects of carbofuran (2,3-dihydro-2,2-dimethyl-7-benzo-furanol N-methylcarbamate) on the functions of T cells in splenocytes and peritoneal macrophages were examined in view of T-cell-mediated immune response (CMIR) in male C57BL/6 mice. Intraperitoneal administration of carbofuran (0.075, 0.15 and 0.3 mg/kg body weight) resulted in significant suppression of delayed type hypersensitivity (DTH), indicating that it caused the suppression of CMIR. Carbofuran decreased Concanavalin A (Con A)- and alloantigen-induced proliferation, and interleukin (IL)-2 production of splenocytes. In vitro addition of rIL-2 could not completely restore the suppressed T-cell proliferation, and IL-2-induced proliferation of Con A-activated splenocytes was also suppressed, which implied that carbofuran caused defects in IL-2 production and responsiveness of splenocytes to IL-2, leading to the suppression of T-cell proliferation. Con A-induced production of interferon-gamma (IFN-gamma) was significantly suppressed by carbofuran, while that of IL-4 was not affected. The production of transforming growth factor-beta from splenocytes was also significantly inhibited by carbofuran. Judging from these results, carbofuran might directly suppress the cytokine production in T helper 1 (Th1) cells. In addition, IFN-gamma-induced production of nitric oxide (NO) in macrophages was also inhibited by carbofuran, which might be one of the important mechanisms of carbofuran-induced CMIR suppression in mice. Collectively, the present study suggests that carbofuran might suppress CMIR through the suppression of T-cell responsiveness, IFN-gamma production in Th1 cells, and NO generation in macrophages.


Assuntos
Carbofurano/toxicidade , Citocinas/metabolismo , Macrófagos/efeitos dos fármacos , Óxido Nítrico/metabolismo , Linfócitos T/efeitos dos fármacos , Animais , Peso Corporal/efeitos dos fármacos , Carbofurano/uso terapêutico , Divisão Celular/efeitos dos fármacos , Concanavalina A/farmacologia , Citocinas/antagonistas & inibidores , Modelos Animais de Doenças , Interações Medicamentosas , Hipersensibilidade Tardia/prevenção & controle , Imunidade Celular/efeitos dos fármacos , Inseticidas/uso terapêutico , Inseticidas/toxicidade , Interferon gama/metabolismo , Interleucina-2/metabolismo , Interleucina-4/metabolismo , Isoantígenos/farmacologia , Macrófagos/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Óxido Nítrico/antagonistas & inibidores , Tamanho do Órgão/efeitos dos fármacos , Baço/citologia , Baço/efeitos dos fármacos , Linfócitos T/imunologia , Fator de Crescimento Transformador beta/metabolismo
4.
Biochem Pharmacol ; 60(5): 677-85, 2000 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-10927026

RESUMO

Ginseng saponins exert various important pharmacological effects with regard to the control of many diseases including cancer. The novel intestinal bacterial metabolites of ginseng protopanaxadiol saponins have recently been found and isolated after the oral administration of ginseng extract in human and rats. 20-O-(beta-D-Glucopyranosyl)-20(S)-protopanaxadiol (IH-901) formed from ginsenosides Rb1, Rb2, and Rc is of particular interest in cancer chemoprevention and treatment. We investigated the effects of IH-901 on the human myeloid leukemia cell line HL-60 in terms of inhibition of proliferation and induction of apoptosis. IH-901 showed a significant cytotoxic activity in HL-60 cells (IC(50) = 24. 3 microM) following a 96-hr incubation. Treatment of HL-60 cells with IH-901 resulted in the formation of internucleosomal DNA fragments. The dose- and time-dependent induction of apoptosis by IH-901 was demonstrated in sandwich enzyme immunoassay and the results were confirmed by flow cytometric analysis. Morphological examination of IH-901-treated samples showed cells with chromatin condensation, cell shrinkage, and nuclear fragmentation, all typical characteristics of apoptotic cells. The treatment of HL-60 cells with IH-901 caused activation of caspase-3 protease and subsequent proteolytic cleavage of poly(ADP-ribose) polymerase. IH-901 did not affect the expression of antiapoptotic protein Bcl-2 but did cause a release of mitochondrial cytochrome c into cytosol. In conclusion, our results demonstrate that IH-901 dramatically suppresses HL-60 cell growth by inducing programed cell death through activation of caspase-3 protease, which occurs via mitochondrial cytochrome c release independently of Bcl-2 modulation. These results may provide a pivotal mechanism for the use of IH-901 in the prevention and treatment of leukemia.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Apoptose , Caspases/metabolismo , Ginsenosídeos , Mucosa Intestinal/metabolismo , Saponinas/farmacologia , Triterpenos/farmacologia , Western Blotting , Caspase 3 , Divisão Celular/efeitos dos fármacos , Grupo dos Citocromos c/metabolismo , Ativação Enzimática/efeitos dos fármacos , Células HL-60 , Humanos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/enzimologia , Panax/química , Plantas Medicinais , Saponinas/metabolismo
5.
Arch Pharm Res ; 23(6): 626-32, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11156186

RESUMO

Brazilin, an active principle of Caesalprenia sappan, was examined for its immunopotentiating effects in multiple low dose streptozotocin (MLD-STZ) induced type diabetic mice. Brazilin was intraperitoneally administered for 5 consecutive days to MLD-STZ induced type I diabetic mice. Delayed type hypersensitivity, Con A-induced proliferation of splenocytes and mixed lymphocyte reaction, which had been decreased in diabetic mice, were significantly recovered by the administration of brazilin. Brazilin increased IL-2 production without affecting suppressor cell activity. Con A-induced and IL-2-induced expression of high affinity IL-2 receptors were also enhanced by brazilin. These results indicate that brazilin augments cellular immune responses, which are suppressed in the MLD-STZ induced type I diabetic mice, by increasing IL-2 production and responsiveness of immune cells to IL-2.


Assuntos
Benzopiranos/farmacologia , Diabetes Mellitus Experimental/imunologia , Hipoglicemiantes/farmacologia , Imunidade Celular/efeitos dos fármacos , Adjuvantes Imunológicos/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Concanavalina A/metabolismo , Ciclosporina/farmacologia , Diabetes Mellitus Experimental/metabolismo , Hipersensibilidade Tardia/imunologia , Hipersensibilidade Tardia/metabolismo , Interleucina-2/biossíntese , Teste de Cultura Mista de Linfócitos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Receptores de Interleucina-2/biossíntese , Baço/citologia , Baço/imunologia , Baço/metabolismo , Linfócitos T Reguladores/efeitos dos fármacos , Linfócitos T Reguladores/imunologia
6.
Biochem Pharmacol ; 58(11): 1705-12, 1999 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-10571244

RESUMO

The effects of brazilin on glucose transport into isolated rat epididymal adipocytes were investigated. Brazilin increased [3H]2-deoxy-D-glucose uptake, which was characterized by an increase in Vmax with no effect on the Km value. Phenylarsine oxide, which inhibits the translocation of glucose transporters, decreased brazilin-stimulated glucose transport to the basal level. The inhibition of phosphatidylinositol 3-kinase (PI3-kinase) with wortmannin also blocked brazilin-stimulated glucose transport. Western blot analysis with an anti-GLUT4 antibody revealed that brazilin increased the translocation of GLUT4 from intracellular pools to the plasma membrane. Brazilin, in combination with phorbol ester, showed an additive effect on glucose transport. The stimulating effect of phorbol ester on glucose transport was inhibited by staurosporine, but the effect of brazilin remained unchanged. Protein kinase C activity was not influenced by brazilin treatment. The inhibition of protein synthesis showed no effect on brazilin-stimulated glucose transport, and GLUT4 content in the total membrane fraction was not altered as a result of treatment with brazilin for 4 hr. Metabolic labeling of GLUT4 with [35S]methionine showed that de novo synthesis of GLUT4 was not induced by brazilin. These data suggest that brazilin may increase glucose transport by recruitment of GLUT4 from intracellular pools to the plasma membrane of adipocytes via the activation of PI3-kinase. However, the effect of brazilin may not be mediated by GLUT4 synthesis and protein kinase C activation.


Assuntos
Adipócitos/efeitos dos fármacos , Benzopiranos/farmacologia , Hipoglicemiantes/farmacologia , Proteínas de Transporte de Monossacarídeos/metabolismo , Proteínas Musculares , Adipócitos/metabolismo , Animais , Transporte Biológico/efeitos dos fármacos , Epididimo/citologia , Glucose/metabolismo , Transportador de Glucose Tipo 4 , Técnicas In Vitro , Masculino , Proteínas de Transporte de Monossacarídeos/biossíntese , Proteína Quinase C/metabolismo , Ratos , Ratos Sprague-Dawley
7.
Cancer Lett ; 144(1): 39-43, 1999 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-10503876

RESUMO

The in vitro antitumor activity of a novel ginseng saponin metabolite, 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol (IH-901), was examined against four human cancer cell lines and one subline resistant to cisplatin (CDDP). The growth inhibitory activity of the compound was estimated by MTT tetrazolium assay. The mean concentrations of IH-901 needed to inhibit the proliferation of the cells by 50% (IC50) were 24.3, 25.9, 56.6 and 24.9 microM against human myeloid leukemia (HL-60), pulmonary adenocarcinoma (PC-14), gastric adenocarcinoma (MKN-45) and hepatoma (HepG2) cell lines, respectively. These values are higher than that of CDDP. In the CDDP-resistant PC/DDP cell line, the IC50 values of IH-901 and CDDP were 20.3 and 60.8 microM, respectively. These results suggest that IH-901 is not cross-resistant to CDDP in this cell line and could be a candidate for the treatment of CDDP resistant pulmonary cancer.


Assuntos
Adenocarcinoma/tratamento farmacológico , Antineoplásicos/farmacologia , Cisplatino/farmacologia , Ginsenosídeos , Neoplasias Pulmonares/tratamento farmacológico , Saponinas/farmacologia , Triterpenos/farmacologia , Adenocarcinoma/patologia , Resistencia a Medicamentos Antineoplásicos , Humanos , Neoplasias Pulmonares/patologia , Células Tumorais Cultivadas
8.
Arch Pharm Res ; 21(6): 769-73, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9868554

RESUMO

Brazilin was examined for its effects on the induction of immunological tolerance. Brazilin was administered to C57BL/6 female mice for 2 consecutive days before the immunization with high dose SRBC (10(9) cells) which can produce immunological tolerance. Delayed type hypersensitivity, IgM plaque forming cells, ConA induced IL-2 production and mitogen- or antigen-induced proliferation of lymphocytes were measured as evaluation parameters. Administration of brazilin prior to immunization could keep the DTH and IL-2 production almost optimally immunized levels. Brazilin also inhibited the elevation of non-specific suppressor cell activity. ConA induced proliferation of splenocytes in high dose SRBC immunized mice was significantly decreased by pretreatment of brazilin. And this might be one of the reason for augmentation of DTH by brazilin. However, IgM plaque forming cells were not affected by the treatment of brazilin. These results indicate that brazilin prevents the induction of immunological tolerance caused by high dose SRBC by suppressing the elevation of suppressor cell activity and by inhibiting the decrease in IL-2 production in C57BL/6 female mice.


Assuntos
Adjuvantes Imunológicos/farmacologia , Benzopiranos/farmacologia , Tolerância Imunológica/efeitos dos fármacos , Animais , Eritrócitos/imunologia , Feminino , Hipersensibilidade Tardia , Imunoglobulina M/efeitos dos fármacos , Técnicas In Vitro , Interleucina-2/biossíntese , Interleucina-2/farmacologia , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos C57BL , Ovinos , Linfócitos T Reguladores/efeitos dos fármacos , Linfócitos T Reguladores/imunologia
9.
Arch Pharm Res ; 21(6): 774-8, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9868555

RESUMO

Brazilin (7,11b-dihydrobenz[b]indeno[1,2-d]pyran-3,6a,9,10 (6 H)-tetrol) inhibited thrombin-,collagen- and ADP-induced aggregation of washed rat platelets. Thrombin- and collagen-induced ATP release were also inhibited by brazilin in a concentration-dependent manner. Brazilin inhibited the formation of platelet thromboxane A2 caused by thrombin, whereas it had no effect on the prostaglandin D2 formation. Brazilin inhibited [3H]-arachidonic acid liberation from membrane phospholipids of thrombin-stimulated platelets. Brazilin inhibited the rise of intracellular free calcium caused by thrombin. These results indicate that the inhibition of phospholipase (PLA2) activity and [Ca2+]i elevation might be at least a part of antiplatelet mechanism of brazilin.


Assuntos
Benzopiranos/farmacologia , Plaquetas/efeitos dos fármacos , Cálcio/metabolismo , Fosfolipases A/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Ácido Araquidônico/metabolismo , Plaquetas/metabolismo , Feminino , Técnicas In Vitro , Fosfolipases A2 , Agregação Plaquetária , Prostaglandina D2/metabolismo , Ratos , Ratos Sprague-Dawley , Tromboxano B2/metabolismo
10.
Planta Med ; 64(6): 500-3, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9741293

RESUMO

Ginseng saponin metabolites produced by human intestinal bacteria were evaluated for antigenotoxic properties by testing their effects on benzo[a]pyrene (B[a]P)-induced mutagenicity and clastogenicity. They include 20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol (IH-901), 20-O-(alpha-D-arabinopyranosyl(1-->6)-beta-D-glucopyranosyl]- 20(S)-protopanaxadiol (IH-902) and 20-O-[alpha-D-arabinofuranosyl(1-->6)-beta-D-glucopyranosyl]-20(S)- protopanaxadiol (IH-903). IH-901, IH-902 and IH-903 inhibited the mutagenicity of B[a]P in a dose-dependent manner. In the chromosome aberration assay, IH-901 and IH-903 reduced the frequency of chromosome aberration induced by B[a]P. These results suggest that the ginseng saponin metabolites tested in the present study have potential as chemopreventive agents.


Assuntos
Antimutagênicos/química , Antimutagênicos/farmacologia , Benzo(a)pireno/toxicidade , Aberrações Cromossômicas , Intestinos/microbiologia , Microssomos Hepáticos/metabolismo , Panax , Plantas Medicinais , Salmonella typhimurium/genética , Saponinas/metabolismo , Saponinas/farmacologia , Animais , Benzo(a)pireno/antagonistas & inibidores , Linhagem Celular , Cricetinae , Cricetulus , Humanos , Pulmão , Masculino , Testes de Mutagenicidade , Ratos , Ratos Sprague-Dawley , Salmonella typhimurium/efeitos dos fármacos , Troca de Cromátide Irmã
11.
Arch Pharm Res ; 21(2): 140-6, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9875421

RESUMO

Hypoglycemic action of brazilin was found to be based on the improvement of peripheral glucose utility, and this action might be correlated with the insulin action pathway. In the present study we investigated the effect of brazilin on the insulin receptor autophosphorylation, protein kinase C (PKC), protein phosphatase and insulin receptor serine kinase in order to confirm whether the hypoglycemic mechanism is concerned with insulin action pathway. Brazilin was found to inhibit PKC and insulin receptor serine kinase, which are involved in the regulation of insulin signal pathway. But any significant effect was not shown on insulin receptor tyrosine kinase activity, autophosphorylation and phosphatase activity. These findings suggest that brazilin might enhance insulin receptor function by decreasing serine phosphorylation, which might mediate hypoglycemic effect of brazilin.


Assuntos
Benzopiranos/farmacologia , Inibidores Enzimáticos/farmacologia , Fígado/enzimologia , Proteína Quinase C/antagonistas & inibidores , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Animais , Insulina/metabolismo , Fígado/efeitos dos fármacos , Masculino , Fosfoaminoácidos/metabolismo , Monoéster Fosfórico Hidrolases/metabolismo , Fosforilação , Ratos , Ratos Sprague-Dawley , Receptor de Insulina
12.
Planta Med ; 63(5): 400-4, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9342941

RESUMO

To investigate the effects of brazilin on the altered immune functions in the early phase of halothane intoxication in mice, several immune functions were investigated. Halothane was found to alter the immune functions which lead to hepatitis by autoimmune-mediated process. Based on the fact that immunomodulation at an initial step of autoimmune diseases is effective to prevent or control the diseases, in the present study the effects of brazilin on the altered immune functions in the early phase of halothane intoxication of C57BL/6 mice were investigated. By the treatment of halothane, delayed type hypersensitivity (DTH) and mitogen (ConA, LPS) induced proliferation of splenocytes were significantly increased and suppressor cell activity and mixed lymphocyte reaction (MLR) were decreased in C57BL/6 mice. But IgM plaque forming cells (PFCs) were not significantly changed. All the parameters tested were changed in homing patterns by the treatment with brazilin. But brazilin significantly increased IgM PFCs to higher than the normal level.


Assuntos
Benzopiranos/farmacologia , Halotano/toxicidade , Hipersensibilidade Tardia , Ativação Linfocitária/efeitos dos fármacos , Linfócitos T Reguladores/imunologia , Animais , Células Cultivadas , Concanavalina A , Transfusão de Eritrócitos , Feminino , Técnica de Placa Hemolítica , Imunoglobulina M/imunologia , Lipopolissacarídeos , Teste de Cultura Mista de Linfócitos , Camundongos , Camundongos Endogâmicos C57BL , Ovinos , Linfócitos T Reguladores/efeitos dos fármacos
13.
Planta Med ; 63(5): 405-8, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9342942

RESUMO

Previously we reported that brazilin, the main principle of Caesalpinia sappan, was able to improve the altered immune functions caused by halothane administration in mice. To elucidate the mechanisms of its immunomodulating activities, the effects of brazilin on the functions of T cells and splenic cellularity were investigated. Brazilin decreased splenic cellularity and IL-2 production which had been augmented in mice treated with halothane (21.5% in olive oil, 10 mmol/kg) for 4 consecutive days whereas the reduced expression of IL-2 receptors by ConA or standard IL-2 was increased by brazilin treatment. These data indicate that halothane induced a dysfunction of T cells resulting in abnormal immune responses and these altered immune functions might be improved mainly by affecting the function of T cells.


Assuntos
Benzopiranos/farmacologia , Halotano/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Linfócitos T/efeitos dos fármacos , Animais , Células Cultivadas , Concanavalina A/farmacologia , Fabaceae , Feminino , Interleucina-2/biossíntese , Interleucina-2/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Lectinas de Plantas , Plantas Medicinais , Receptores de Interleucina-2/biossíntese , Baço/imunologia , Linfócitos T/imunologia
14.
Biochem Pharmacol ; 54(2): 259-68, 1997 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-9271330

RESUMO

The effects of 2-[(4-acetylphenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15), a synthetic 1,4-naphthoquinone derivative, on platelet activity and its mechanism of action were investigated. NQ-Y15 caused a concentration-dependent inhibition of the aggregation induced by thrombin, collagen, arachidonic acid (AA), and A23187. The IC50 values of NQ-Y15 on thrombin (0.1 U/mL)-, collagen (10 microg/mL)-, AA (50 microM)-, and A23187 (2 microM)-induced aggregation were 36.2 +/- 1.5, 6.7 +/- 0.7, 35.4 +/- 1.7, and 93.1 +/- 1.4 microM, respectively. NQ-Y15 also inhibited thrombin-, collagen-, AA-, and A23187-stimulated serotonin secretion in a concentration-dependent manner. However, a high concentration (100 microM) of NQ-Y15 showed no significant inhibitory effect on ADP-induced primary aggregation, which is independent of thromboxane A2 (TXA2) production in rat platelets. In fura-2-loaded platelets, the elevation of intracellular free calcium concentration stimulated by AA, thrombin, and 4-bromo-A23187 was inhibited by NQ-Y15 in a concentration-dependent manner. The formation of TXA2 caused by AA, thrombin, and collagen was inhibited significantly by NQ-Y15. NQ-Y15 inhibited TXA2 synthase in intact rat platelets, since this agent reduced the conversion of prostaglandin (PG) H2 to TXA2. Similarly, NQ-Y15 selectively inhibited the TXA2 synthase activity in human platelet microsomes, whereas it had no effect on activity of phospholipase A2, cyclooxygenase, and PGI2 synthase in vitro. NQ-Y15 inhibited platelet aggregation induced by the endoperoxide analogue U46619 in human platelets, indicating TXA2 receptor antagonism, possibly of a competitive nature. These results suggest that the antiplatelet effect of NQ-Y15 is due to a combination of TXA2 synthase inhibition with TXA2 receptor blockade, and that it may be useful as an antithrombotic agent.


Assuntos
Plaquetas/efeitos dos fármacos , Naftoquinonas/farmacologia , Inibidores da Agregação Plaquetária/farmacologia , Receptores de Tromboxanos/antagonistas & inibidores , Tromboxano-A Sintase/antagonistas & inibidores , Animais , Plaquetas/metabolismo , Cálcio/metabolismo , Feminino , Prostaglandina-Endoperóxido Sintases/metabolismo , Ratos , Ratos Sprague-Dawley , Serotonina/metabolismo , Tromboxano A2/antagonistas & inibidores , Tromboxano B2/metabolismo
15.
Biochem Pharmacol ; 54(1): 97-101, 1997 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-9296355

RESUMO

Brazilin increased [3H]2-deoxyglucose uptake in isolated rat epididymal adipocytes. The fact that calcium may be required for the stimulatory effects of insulin on glucose transport suggests that brazilin might also require calcium for its glucose transport-stimulating action. Changes in the concentration of extracellular calcium had no significant effect on brazilin-induced glucose transport. Nifedipine and verapamil decreased brazilin-induced glucose transport, and quin2-AM abolished the effect of brazilin on glucose transport. A23187, however, showed no effect on brazilin action. 45Ca2+ uptake into adipocytes was not influenced by brazilin treatment, and trifluoperazine significantly inhibited the effect of brazilin on glucose transport. These data suggest that calmodulin and the maintenance of the intracellular calcium concentration, rather than an increase in it, may be essential for the stimulatory action of brazilin on glucose transport.


Assuntos
Adipócitos/efeitos dos fármacos , Benzopiranos/farmacologia , Cálcio/farmacologia , Glucose/metabolismo , Hipoglicemiantes/farmacologia , Adipócitos/metabolismo , Animais , Benzopiranos/antagonistas & inibidores , Transporte Biológico/efeitos dos fármacos , Calcimicina/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Calmodulina/metabolismo , Membrana Celular/metabolismo , Relação Dose-Resposta a Droga , Epididimo/metabolismo , Antagonistas da Insulina/farmacologia , Masculino , Nifedipino/farmacologia , Ratos , Ratos Sprague-Dawley , Trifluoperazina/farmacologia , Verapamil/farmacologia
16.
Mol Cells ; 7(6): 742-8, 1997 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-9509415

RESUMO

Insulin has pleiotropic effects on the regulation of cellular growth, differentiation, and metabolism. The biochemical events ultimately leading to cell proliferation after insulin treatment have been demonstrated in detail by numerous research groups. However, depending on cell types, it has been shown that insulin has various effects on cell proliferation. Therefore, we attempted to more critically evaluate the effect of insulin on cell proliferation in 3T3 L1 fibroblasts. In this study, we investigated insulin's effect on cell proliferation by using [3H]thymidine incorporation, flow cytometry, and cell counting. In 3T3 L1 fibroblasts studied in 0.5% serum, insulin induced a two-fold increase in [3H]thymidine incorporation over at 48 h, and the maximal rate of DNA synthesis was observed during 8-12 h incubation. The flow cytometric analysis also showed that insulin increased the cell population in the S phase. After insulin treatment for 48 h, cell numbers increased approximately 45% in comparison with 0.5% serum control. Cell division was found to occur only once in 60 h after staining 3T3 L1 fibroblasts with carboxyfluorescein diacetate succinimidyl ester (CFSE). Taken together, this data indicates that insulin stimulated the transit from the G0/G1 to S phase, progressed the cell cycle through the G2/M phase, and increased the cell number. However, under our experimental conditions, cells divided only once in 60 h in the presence of insulin.


Assuntos
Ciclo Celular/efeitos dos fármacos , Insulina/farmacologia , Células 3T3 , Animais , Contagem de Células/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Replicação do DNA/efeitos dos fármacos , Citometria de Fluxo , Fluoresceínas/metabolismo , Corantes Fluorescentes , Interfase/fisiologia , Camundongos , Mitose/efeitos dos fármacos , Mitose/fisiologia , Fase S/fisiologia , Succinimidas/metabolismo
17.
Planta Med ; 61(4): 297-301, 1995 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7480173

RESUMO

Brazilin (7,11b-dihydrobenz[b]indeno-[1,2-d]pyran-3,6a,9,10(6H)- tetrol) was found to have hypoglycemic action and increase glucose metabolism in experimental diabetic animals. In order to investigate the mechanism of hypoglycemic action of brazilin, the effects of brazilin on glucose transport, insulin receptor autophosphorylation, and protein kinase C(PKC) activity in 3T3-L1 cells were studied. Brazilin increased basal glucose transport in 3T3-L1 fibroblasts and adipocytes. However, insulin-stimulated glucose transport was not influenced. Autophosphorylation of the partially purified insulin receptor was not affected by brazilin treatment in 3T3-L1 fibroblasts. However, brazilin decreased the PKC activity in 3T3-L1 fibroblasts and adipocytes.


Assuntos
Adipócitos/metabolismo , Benzopiranos/farmacologia , Glucose/metabolismo , Células 3T3 , Adipócitos/efeitos dos fármacos , Animais , Transporte Biológico/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Insulina/farmacologia , Camundongos , Proteína Quinase C/metabolismo , Receptor de Insulina/metabolismo
18.
Development ; 121(3): 825-37, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7720586

RESUMO

This study investigates the migration patterns of cranial neural crest cells in retinoic acid (RA)-treated rat embryos using DiI labeling. Wistar-Imamichi rat embryos were treated at the early (9.0 days post coitum, d.p.c.) and late (9.5 d.p.c.) neural plate stages with all-trans RA (2 x 10(-7) M) for 6 hours and further cultured in an RA-free medium. RA exposure stage dependently induced two typical craniofacial abnormalities; that is, at 9.0 d.p.c. it reduced the size and shape of the first branchial arch to those of the second arch, whereas, in contrast, at 9.5 d.p.c. it induced fusion of the first and second branchial arches. Early-stage treatment induced an ectopic migration of the anterior hindbrain (rhombomeres (r) 1 and 2) crest cells; they ectopically distributed in the second branchial arch and acousticofacial ganglion, as well as in their original destination, i.e., the first arch and trigeminal ganglion. In contrast, late-stage treatment did not disturb the segmental migration pattern of hindbrain crest cells even though it induced the fused branchial arch (FBA); labeled crest cells from the anterior hindbrain populated the anterior half of the FBA and those from the preotic hindbrain (r3 and r4) occupied its posterior half. In control embryos, cellular retinoic acid binding protein I (CRABP I) was strongly expressed in the second branchial arch, r4 and r6, while weakly in the first arch and r1-3. CRABP I was upregulated by the early-stage treatment in the first branchial arch and related rhombomeres, while its expression was not correspondingly changed by the late-stage treatment. Moreover, whole-mount neurofilament staining showed that, in early-RA-treated embryos, the typical structure of the trigeminal ganglion vanished, whereas the late-stage-treated embryos showed the feature of the trigeminal ganglion to be conserved, although it fused with the acousticofacial ganglion. Thus, from the standpoints of morphology, cell lineages and molecular markers, it seems likely that RA alters the regional identity of the hindbrain crest cells, which may correspond to the transformation of the hindbrain identity in RA-treated mouse embryos (Marshall et al., Nature 360, 737-741, 1992).


Assuntos
Crista Neural/citologia , Rombencéfalo/embriologia , Tretinoína/farmacologia , Animais , Região Branquial/efeitos dos fármacos , Movimento Celular/efeitos dos fármacos , Ossos Faciais/anormalidades , Ossos Faciais/metabolismo , Idade Gestacional , Imuno-Histoquímica , Microscopia Eletrônica de Varredura , Morfogênese/efeitos dos fármacos , Crista Neural/efeitos dos fármacos , Fenótipo , Ratos , Ratos Wistar , Receptores do Ácido Retinoico/metabolismo , Rombencéfalo/citologia , Crânio/anormalidades , Crânio/metabolismo
19.
Life Sci ; 57(6): 571-8, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7623624

RESUMO

This study was initiated to investigate the possible involvement of prostaglandin H synthase in the staurosporine-induced prostaglandin production. The time course of prostaglandin H synthase activity in macrophages treated with staurosporine (20 nM) showed that the maximum activity was reached in 20 h. The stimulatory effect of staurosporine on thromboxane B2 production was maximum at 50 nM staurosporine and this effect was reversed at higher concentrations. Immunoprecipitation of 35S-labeled enzyme using an antibody specific for prostaglandin H synthase-2 paralleled the changes in enzyme activity. These results indicate that increased de novo synthesis of prostaglandin H synthase-2 is largely, if not solely, responsible for staurosporine-stimulated prostaglandin production in macrophages.


Assuntos
Alcaloides/farmacologia , Macrófagos Alveolares/efeitos dos fármacos , Prostaglandina-Endoperóxido Sintases/efeitos dos fármacos , Animais , Relação Dose-Resposta a Droga , Macrófagos Alveolares/metabolismo , Testes de Precipitina , Prostaglandina-Endoperóxido Sintases/biossíntese , Ratos , Ratos Sprague-Dawley , Estaurosporina , Tromboxano B2/biossíntese
20.
Biochem Pharmacol ; 46(11): 2111-3, 1993 Dec 03.
Artigo em Inglês | MEDLINE | ID: mdl-8267663

RESUMO

The present study was conducted to determine whether degradation products of streptozotocin formed under various conditions induce hyperglycemia in rats. Streptozotocin is completely degraded in pH 7.4 buffer in 4 hr and even more rapidly in plasma. Streptozotocin degradation products resulting from incubation in pH 7.4 phosphate buffer or in plasma were not diabetogenic in rats.


Assuntos
Hiperglicemia/induzido quimicamente , Estreptozocina/farmacocinética , Animais , Glicemia/análise , Feminino , Concentração de Íons de Hidrogênio , Ratos , Ratos Sprague-Dawley , Estreptozocina/administração & dosagem , Estreptozocina/química , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA